MEDICAL DEVICE NEWS MAGAZINE

Monday, August 15, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

Manipal Hospitals, Delhi Reports a 27 Year Old Female Patient from Iraq Was Successfully Treated for Systemic Lupus Erythematosus

Doctors at Manipal Hospitals, Delhi, successfully treated a 27-year-old female patient from Iraq with advanced robotic mitral valve repair. The patient was suffering from Systemic Lupus Erythematosus (SLE) and cardiac problem, she was getting treatment at a local hospital in Iraq however she was not getting any relief from the treatment.

She was then referred to Dr. Yugal Kishore Mishra, Head of Cardiac Sciences and Chief Cardiovascular Surgeon at Manipal Hospital, Delhi for an advanced and high cardiac surgery. The patient came to the hospital with a complaint experiencing breathlessness, heaviness in the chest, and tiredness for the last 2 years. She was not very comfortable with the traditional stenosis surgery, that’s when Dr. Yugal Kishore Mishra and his team decided to perform a robotic mitral valve repair on the patient.

In this case, the patient had Systemic Lupus Erythematosus (SLE), a chronic autoimmune illness that can cause inflammation in the heart and other organs. The condition can influence heart ailment which can be observed in over half of lupus patients.

The doctors chose to proceed with a robotic MVR as robotic surgeries have proven to be one of the most effective methods and is beneficial for the patient. The doctors also used a Cor-Knot technology, which allows them to tie the knot in as little as 2-3 minutes, avoiding any unnecessary delays.

As robotic surgeries are minimally invasive procedures, the pain is very minimal because such a procedure does not require spreading the ribs or cutting any bones for the surgery. Therefore, a patient can recover within 2-3 weeks from the surgery, and the chances of infection are also minimal.

Commenting on the uniqueness of this case, Dr. Y K Mishra, Head, Cardiac Sciences and Chief Cardiovascular Surgeon, Manipal Hospital, Delhi said, “This case is unique as the patient was suffering from the condition right from the age of 5 years. On diagnosis, we found that her valve was also calcified like a stone, but as she did not want her chest bone to be split, we opted for robotic surgery to perform the mitral valve repair with accuracy. During this procedure, a small 3-inch cut underneath her breast was done to avoid her splitting of the sternum. Robotic surgeries can have a lot of benefits, they are not only beneficial for accuracy, but are also very cosmetically good as compared to conventional surgeries. The patient recovered quickly and was put off the ventilator support on the very next day. ”

With the advancement of medical technology all over the world, there are several treatment options that allow patients to get treatment with minimal cuts and faster recovery options. Manipal Hospitals aims to bring in advanced therapies and procedures from different parts of the world to provide the best healthcare facilities to people across India. Manipal Hospital, Delhi has one of the most advanced cardiac departments in Delhi NCR using minimally invasive and robotic surgery.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

"These data demonstrate that the Hemopurifier can effectively capture a wide range of clinically relevant SARS-CoV-2 variants," said Charles J. Fisher, M.D., Chief Executive Officer of Aethlon Medical.

Adagio Medical Announces Publication of Cryocure-2 Data

"The publication of Cryocure-2 data is seen as a significant step in the validation of Adagio's ULTC technology," said Olav Bergheim, President and CEO of Adagio Medical.

Artivion Initiates Enrollment in PERSEVERE Clinical Trial

Artivion advises the trial is designed to support the company's forthcoming application to the U.S. Food and Drug Administration for premarket approval of the AMDS.

By using this website you agree to accept Medical Device News Magazine Privacy Policy